Clinical Trials Browser

Phase 4 × Hemorrhage × Rivaroxaban × Clear all

NCT01989845 2017-01-09

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Phase 4 Completed

Hemorrhage, Recurrence